Sign in

CIK 0001737287

  • Non-accelerated filer
  • Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
823562771
Phone
+1 650-457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,698
in 1 filing

Net −$48,698. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Parker Geoffrey M. −$49K CHIEF FINANCIAL OFFICER sold 3% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-18 Mayo Stephen Director Grant or award · Stock Option (Right to buy) +144,400 144,400
2025-06-18 Mayo Stephen Director Grant or award · Restricted Stock Unit +95,400 95,400
2024-06-05 Mayo Stephen Director Grant or award · Stock Option (Right to buy) +191,082 191,082
2023-08-07 Mayo Stephen Director Sale −10,000 $4.29 $43K 25,328
2023-06-13 Mayo Stephen Director Grant or award · Stock Option (Right to Buy) +116,120 116,120
2022-07-08 Mayo Stephen Director Grant or award +35,328 35,328
2022-07-08 Mayo Stephen Director Grant or award · Stock Option (Right to Buy) +54,487 54,487

Page 1 of 1 · 7 trades